Ana M. Ciurea, M.D.
Department of Dermatology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Professor, Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Dermatology, Division of Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Research Interests
Malignant melanoma
Cutaneous toxicities related to various chemotherapeutic agents
Cutaneous infectious diseases
Education & Training
Degree-Granting Education
| 1996 | University of Medicine and Pharmaceuticals, Iasi, RO, MD |
Postgraduate Training
| 2007-2008 | Chief Resident, Dermatology, Northwestern University, Chicago, Illinois |
| 2005-2008 | Resident, Dermatology, Northwestern University, Chicago, Illinois |
| 2004-2005 | Research Fellowship, Dermatology, Northwestern University, Chicago, Illinois |
| 2003-2004 | Chief Resident, Internal Medicine, Penn State University (Pinnacle Health Hospital), Harrisburg, Pennsylvania |
| 2001-2004 | Resident, Internal Medicine, Penn State University (Pinnacle Health Hospital), Harrisburg, Pennsylvania |
| 1997-2000 | Resident, Pediatrics, St. Maria University Hospital, Iasi |
Licenses & Certifications
| 2008 | Texas Medical Board |
| 2008 | American Board of Dermatology |
| 2008 | DEA |
| 2004 | American Board of Internal Medicine |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019
Assistant Professor, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2008 - 2013
Administrative Appointments/Responsibilities
Project Director of Dermatology, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - Present
Associate Medical Director, Cancer Prevention Clinic, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present
Other Professional Positions
Visiting Professor, Gr. T. Popa University of Medicine and Pharmacy, Iasi, 2017 - Present
Extramural Institutional Committee Activities
Member, Dermatopathology Faculty Search Commitee, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Member, Dermatology Department Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Patient Care Committee, Faculty Excellence Awards Review Board, The University of Texas MD Anderson Cancer Center, 2018 - 2018
Research Grants Programs, Study Section Review Committee for Clinical Translational and Population-Based Research Projects, The University of Texas MD Anderson Cancer Center, 2011 - 2014
Member, Institutional Review Board 5, The University of Texas MD Anderson Cancer Center, 2011 - 2012
Editorial Activities
Editor, Nature Research, 2019 - 2020
Reviewer, Archives of clinical cases, 2016 - 2017
Reviewer, Journal of Immunotherapy, 2015 - 2016
Honors & Awards
| 2024 - Present | Top performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2023 | Faculty Honoree, Community Outreach |
| 2023 | Top Performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2022 | Top Performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2020 | Top Performer 10%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2019 | Top Performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2018 | Top Performer 10%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2017 | Top performer 1%, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2007 | Women's Dermatologic Society Mentorship Award |
| 2006 | Society of Investigative Dermatology Resident Retreat for Future Academicians Award |
| 2004 | Internal Medicine Resident of the Year Award |
| 2003 | Best Scientific paper in Clinical Research, Third Virtual Congress of Cardiology, Argentina |
| 1994 | First prize 4th year Annual Scientific Symposium, Iasi |
| 1993 | Third prize 3rd year Annual Scientific Student Symposium, Iasi |
| 1990 - 1996 | Graduated in the top 5% of class |
| 1990 - 1996 | National Merit Scholarship during Medical School |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2021. The Good, The Bad and the Ugly. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2021. Boards Kodachromes. Conference. MDACC. Houston, TX, US.
- 2021. Pearls from Inpatient Dermatology- Board Kodachomes. Conference. MDACC. Houston, TX, US.
- 2021. Boards Kodachromes. Conference. MDACC. Houston, TX, US.
- 2019. Infectious disease mimickers in cancer patients. Conference. Texas Dermatological Society. Houston, TX, US.
- 2017. Melanoma prevention, screening and diagnosis. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2017. Understanding melanoma from prevention to cure. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2016. Melanoma prevention, screening and diagnosis. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2015. Melanoma in the modern millennium: a dermatologist perspective. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2015. Melanoma prevention, screening and diagnosis. Conference. MD Anderson Cancer Center. Houston, TX, US.
- 2011. Mimickers of Infectious Diseases in Cancer Patients. Conference. Division of Internal Medicine Grand Rounds. Houston, TX, US.
- 2011. Introduction to Dermoscopy. Conference. Melanoma Oncology Grand Rounds. Houston, TX, US.
Regional Presentations
- 2019. Panel member. Conference. MD Anderson Cancer Center. Breckenridge, CO, US.
- 2017. Panel member. Conference. MD Anderson Cancer Center. Steamboat, CO, US.
- 2016. Panel Member. Conference. MD Anderson Cancer Center. Steamboat, CO, US.
- 2007. Atypical Mycobacterial Infection an AIDS patient. Conference. Dermatological Society Meeting. Chicago, IL, US.
- 2007. A typical mycobacterium infection in an AIDS patient". Conference. Chicago Dermatological Society Meeting, Northwestern University. Chicago, IL, US.
- 2007. Metastatic malignant melanoma. Conference. Dermatological Society Meeting, Northwest University. Chicago, IL, US.
- 2007. An unusual indolent presentation of intravascular B-cell lymphoma in an elderly female. Conference. American Society of Dermatopathology. Chicago, IL, US.
- 2007. Malignant pyoderma. Conference. AAD Meeting. Washington, DC, US.
- 2006. Malignant Pyoderma. Conference. Dermatological Society Meeting. Chicago, IL, US.
- 2006. Estrogen and skin. Conference. Northwestern University. Chicago, IL, US.
- 2006. Malignant pyoderma. Conference. Residents Research Forum. St. Louis, MO, US.
- 2006. Malignant pyoderma. Conference. Chicago Dermatological Society. Chicago, IL, US.
- 2006. Intravascular B-cell lymphoma. Conference. Chicago Dermatological Society. Chicago, IL, US.
- 2005. Pancreatic Panniculitis as First Sign of Pancreatic Carcinoma. Conference. Dermatological Society Meeting Northwestern University. Chicago, IL, US.
- 2005. Clinical and Histological Response of Early CTCL to Low-Dose Combination Therapy with Bexarotene and Psoralen Plus Ultraviolet A (PUVA). Conference. American Academy of Dermatology. New Orleans, LA, US.
- 2003. Do Doctors Make the Switch: Change in Antibiotic Therapy Based on Blood Culture Results. Conference. American Society of Microbiology. Washington, DC, US.
- 2003. Do Doctors Make the Switch: Change in Antibiotic Therapy Based on Blood Culture Results. Conference. Medical Education Day. Harrisburg, PA, US.
- 2002. A patient with Mycobacterium Kansasii Infection. Conference. Morbidity and Mortality Conference. Harrisburg, PA, US.
National Presentations
- 2020. Melanoma session, Panel Member. Invited. 18th Updated: Advances & Controversies. Steamboat, CO, US.
- 2019. Cutaneous side effects of targeted therapy and immunotherapy. Invited. Updates in Oncology. Iasi, US.
- 2019. Mimickers in dermoscopy. Invited. American Academy of Dermatology. Washington, DC, US.
- 2018. Mimickers in dermoscopy. Invited. American Academy of Dermatology. San Diego, CA, US.
- 2017. Project DERM: Skin cancer health education: Screening services and outcomes in an underserved population in Harris County, TX. Conference. CPRIT. Austin, TX, US.
- 2017. Project DERM: Skin cancer health education: Screening services and outcomes in an underserved population in Harris County, TX. Invited. American Academy of Dermatology. Orlando, FL, US.
- 2017. Mimickers in dermoscopy. Invited. American Academy of Dermatology. Orlando, FL, US.
- 2014. Infectious disease mimickers in cancer patients, Infectious diseases course. Conference. American Academy of Dermatology. Denver, CO, US.
- 2013. Infectious disease mimickers in cancer patients, Infectious diseases course. Invited. American Academy of Dermatology. Miami, FL, US.
- 2012. Dermoscopy of non-melanocytic skin lesions. Invited. American Academy of Dermatology Summer Meeting. Boston, MA, US.
- 2011. Dermoscopy Workshop. Invited. American Academy of Dermatology. New York, NY, US.
- 2011. Merkel cell polymoviurs DNA detection in a patient with Merkel Cell carcinoma and multiple other skin cancers. Invited. American Academy of Dermatology. New Orleans, LA, US.
- 2011. In Situ Photoimmunotherapy: A Tumor-Directed Approach to the Treatment of Advanced Melanoma with Cutaneous Metastases. Conference. In Situ Photoimmunotherapy: A Tumor-Directed Approach to the Treatment of Advanced Melanoma with Cutaneous Metastases. ISIP.
- 2010. High resolution, high magnification capillary video microscopy imaging as a useful adjunct in the assessment of pharmacological intervention (Tadalafil) for secondary Raynaud's phenomenon due to scleroderma and mixed connective tissue disease. Conference. American Academy of Dermatology. Miami, FL, US.
- 2007. Metastatic Melanoma-An Unusual Presentation. Conference. Dermatological Society Meeting. Chicago, IL, US.
- 2007. Atypical Mycobacterial Infection in an AIDS patient. Conference. Dermatological Society Meeting. Chicago, IL, US.
- 2007. Malignant Pyoderma. Conference. AA Meeting. Washington, DC, US.
- 2006. Estrogens and Skin. Conference. Grand Rounds Lecture. Chicago, IL, US.
- 2006. Intravascular B-cell Lymphoma. Conference. Dermatological Society. Chicago, IL, US.
- 2006. Malignant Pyoderma. Conference. Dermatological Society Meeting. Chicago, IL, US.
- 2006. Malignant Pyoderma. Conference. Residents Research Forum. St. Louis, MO, US.
- 2005. Pancreatic Panniculitis as First Sign of Pancreatic Carcinoma. Conference. Residents Research Form. Chicago, IL, US.
- 2005. Clinical and Histological Response of Early CTCL to Low-Dose Combination Therapy with Bexarotene and Psoralen Plus Ultraviolet A (PUVA). Conference. American Academy of Dermatology. New Orleans, LA, US.
- 2003. Do Doctors Make the Switch: Change in Antibiotic Based on Blood Culture Results. Conference. American Society of Microbiology. Washington, DC, US.
- 2003. Do Doctors Make the Switch: Change in Antibiotic Therapy Based on Blood Culture Results. Conference. Do Doctors Make the Switch: Change in Antibiotic Therapy Based on Blood Culture Results. Harrisburg, PA, US.
- 2002. A Patient with Mycobacterium Kansasii Infection. Conference. Morbidity and Mortality Conference. Harrisburg, PA, US.
- 2002. Preoperative Antimicrobial Prophylaxis Administration at Pinnacle Health: How Are We Doing. Conference. Medical Education Day. Harrisburg, PA, US.
International Presentations
- 2021. Skin Cancer Prevention and Screening. Invited. The Conferences of Regional Institute of Oncology Iasi. Iasi, RO.
- 2021. Infectious Diseases in Cancer Patients. Invited. “Zilele Gh. Nastate” Dermatology Conference. Iasi, RO.
- 2021. The Good, The Bad and the Ugly. Invited. International Society of Dermatopathology, US.
- 2020. Clinical Pearls – Inpatient Dermatology. Invited. Dermatology Conference, “Zilele Gh. Nastase. Iasi, RO.
- 2020. Advanced Melanoma – Skin Toxicity of Immunotherapy and Targeted Therapy. Invited. Dermatology Conference, “Zilele Gh. Nastase”. Iasi, RO.
- 2019. Skin Cancer Prevention and Screening in the Modern Millenniumn. Invited. International Society of Dermatopathlogy. Lisbon, PT.
- 2019. Cancer prevention in the modern millennium. Conference. International Society of Dermatopathology. Lisbon, PT.
- 2019. Cancer targeted therapy and immunotherapy - skin toxicities. Invited. Gr. T Popa University of Medicine and Pharmacy. Iasi, RO.
- 2018. Melanoma treatment - a dermatologist perspective. Conference. Romanian National Oncology Institute. Iasi, RO.
- 2018. Melanoma prevention and screening. Invited. Romanian National Oncology Institute. Iasi, RO.
- 2017. Challenging melanocytic lesions. Invited. Gr. T Popa University of Medicine and Pharmacy. Iasi, RO.
- 2016. Images in dermatology – Lessons learned from great cases. Invited. Gr. T Popa University of Medicine and Pharmacy. Iasi, RO.
- 2015. Infectious disease mimickers in cancer patients. Invited. Gr T Popa University of Medicine and Pharmacy. Iasi, RO.
- 2015. Treatment of squamous cell carcinoma. Invited. Simposio Internacional de Dermatologia Oncologica. Medellin, CO.
- 2015. Treatment of basal cell carcinoma. Invited. Simposio Interanacional de Dermatologia Oncologica. Medellin, CO.
- 2015. Pathogenesis of squamous cell carcinoma. Invited. Simposio Internacional de Dermatologia Oncologica. Medellin, CO.
- 2015. Pathogenesis of basal cell carcinoma. Invited. Simposio Internacional de Dermatologia Oncologica. Medellin, CO.
- 2012. Introduction to Dermoscopy. Invited. Dermatological Spring Meeting. Iasi, RO.
- 2012. Dermoscopy in dermatological practice. Invited. Gr. T Popa University of Medicine and Pharmacy. Iasi, RO.
- 2009. Malignant melanoma - a continuous challenge. Invited. University of Medicine and Pharmaceuticals. Iasi, RO.
- 2009. Management of Difficult-to-Treat Psoriasis Vulgaris. Invited. "Gh Nastase" Dermatology Symposium. Iasi, RO.
- 2009. Psoriasis vulgaris, more than an inflammatory skin disorder - Oral Presentation, "Gh Nastase". Invited. "Gh Nastase" Dermatology Symposium. Iasi, RO.
- 2009. In-situ photoimmunotherapy: a tumor directed treatment for stage IV melanoma with cutaneous metastases. Invited. SPIE Photonic West. San Jose, US.
- 1996. The Alcoholic Torsade de Pointes. Conference. The Alcoholic Torsade de Pointes. Iasi, RO.
- 1993. AIDS - Neonatal Infection. Conference. National Symposium. Iasi, RO.
- 1993. AIDS - Spreading and Particularities in Romania. Conference. National Symposium. Iasi, RO.
- 1992. Atrial Natriuretic Peptide - The Cardiac Endocrine Component. Conference. Annual Scientific Student Symposium. Iasi, RO.
Formal Peers
- 2025. Kodachromes. Houston, Texas, US.
- 2024. Kodachromes. Houston, Texas, US.
- 2024. Kodachromes. Houston, Texas, US.
- 2016. Melanoma in the modern millennium: a dermatologist perspective. Invited. Omaha, NE, US.
- 2012. Dermoscopy Unknowns. Invited. Detroit, MI, US.
- 2012. "The Many Faces of Nevi and Melanoma". Invited. Detroit, MI, US.
- 2010. "Mimickers of Infectious Diseases in Cancer Patients:. Invited. Iasi, RO.
- 2010. "Dermal and Subcutaneous Tumors". Invited. Iasi, RO.
Grant & Contract Support
| Date: | 2022 - 2027 |
| Title: | Translating FLASH Radiobiological Insights to Cutaneous Malignancies, |
| Funding Source: | Medicaid |
| Role: | Co-I |
| ID: | FP00015770 |
| Date: | 2015 - Present |
| Title: | Skin Cancer Medicaid Waiver Project |
| Funding Source: | Medicaid |
| Role: | Project Leader |
| ID: | 1115 Waiver DSRIP |
| Date: | 2011 - 2015 |
| Title: | Incidence of cutaneous squamous cell carcinoma and melanoma associated with prolonged use of voriconazole and posaconazole therapy at MD Anderson Cancer Center – 6-year experience |
| Funding Source: | Merck Co |
| Role: | PI |
| ID: | DR0866 |
Selected Publications
Peer-Reviewed Articles
- Lin Pei-Yu, Shen Yidan, Mathew Neville, Hu Renjie, Huang Siyu, Queen M. Courtney, West E. Cameron, Ciurea AM, Zouridakis George. Synthetic Melanoma Image Generation and Evaluation Using Generative Adversarial Networks. Bioengineering 13(2):245, 2026. e-Pub 2026.
- Alam, M, Kim, JY, Swary, JH, White, LE, Ciurea, AM, Dave, L, Brieva, J, Yoo, SS. Health utilities associated with nonmelanoma skin cancer. Journal of the American Academy of Dermatology 90(5):1042-1044, 2024. e-Pub 2024. PMID: 38215795.
- Baig, IT, Nguyen, QB, Hickson, MS, Ciurea, AM. Metastatic adenocarcinoma mimicking hidradenitis suppurativa. JAAD Case Reports 27:91-93, 2022. e-Pub 2022. PMID: 36039336.
- Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Nagarajan P, Curry JL, Ciurea AM, Rubin AI, Hwu WJ, Prieto VG, Aung PP. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma. Arch Pathol Lab Med 145(8):943-952, 2021. e-Pub 2021. PMID: 33290520.
- Clutter CA, Aneja S, Ivan D, Ciurea A, Silapunt S. Cutaneous Lesions of Multiple Myeloma of the Lower Extremity Masquerading as Squamous Cell Carcinoma. Cureus, 2020. e-Pub 2020.
- Ciurea SO, Hansrivijit P, Ciurea AM, Hymes S, Chen J, Champlin RE. Curative Potential of Hematopoietic Stem Cell Transplantation for Advanced Psoriasis. Am J Hematol 94(6):E176-E180, 2019. e-Pub 2019.
- Chen L, Parsons AM, Aria AB, Ciurea AM, Patel AB, Migden MR. Surgical Site Identification with Personal Digital Device: A Prospective Pilot Study. J Am Acad Dermatol 79(3):520-524, 2018. e-Pub 2018.
- Mudaliar K, Tetzlaff MT, Duvic M, Ciurea A, Curry JL. BRAF Inhibitor Therapy-Associated Melanocytic Lesions Lack the BRAF V600E Mutation and Show Increased Levels of Cyclin D1 Expression. Hum Pathol(50):79-89, 2016. e-Pub 2016.
- Yorio JT, Mays SR, Ciurea AM, Cohen PR, Wang WL, Hwu WJ, Gonzalez N, Richard JL, Kim KB. Case of Vemurafenib-Induced Sweet's Syndrome. J Dermatol 41(9):817-20, 2014. e-Pub 2014. PMID: 24617955.
- Vin H, Ching G, Ojeda SS, Adelmann CH, Chitsazzadeh V, Dwyer DW, Ma H, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Ciurea AM, Duvic M, Busaidy NL, Tannir NM, Tsai KY. Sorafenib Suppresses JNK-Dependent Apoptosis Through Inhibition of ZAK. Mol Cancer Ther 13(1):221-9, 2014. e-Pub 2014. PMID: 24170769.
- Farmakiotis D, Ciurea AM, Cahuayme-Zuniga L, Kontoyiannis DP. The Diagnostic Yield of Skin Biopsy in Patients with Leukemia and Suspected Infection. J Infect Dis 67(4):265-72, 2013. e-Pub 2013. PMID: 23769840.
- Mays R, Curry J, Kim K, Tsai K, Arora A, Khan F, Ramirez-Fort M, Ciurea A. Eruptive Squamous Cell Carcinomas After Vemurafenib Therapy. J Cutan Med Surg 17(6):419-22, 2013. e-Pub 2013.
- Rozas-Munoz E, Martinez Escala ME, Wang WL, Ciurea AM, Pujol RM, Prieto VG. A Slowly Growing Plaque on the Lower Back: Challenge. Am J Dermapathol 34(4):452-3, 2012. e-Pub 2012.
- Haitz K, Rady P, Nguyen H, Turing S, Ciurea AM. Merkel Cell Polyomavirus DNA Detection in a Patient with Merkel Cell Carcinoma and Multiple other Skin Cancers. Int J Dermatol 51(4):442-4, 2012. e-Pub 2012.
- Ciurea A, Guitart J, Brieva J. Complete and Durable Response of Malignant Pyoderma to Tacrolimus in Combination with Dapsone and Prednisone. Arch Dermatol 146(1):102-103, 2010. e-Pub 2010.
- St Pierre SA, Rommel J, Ciurea A, Fife D, Yoo SS, Martini M, Kuzel TM, Wayne J, Rademaker A, West DP, Alam M. In Situ Photoimmunotherapy: A Surgery-and Limb-Sparing Approach to the Treatment of Cutaneous Metastases in Advanced Melanoma. Arch Dermatol 146(8):831-4, 2010. e-Pub 2010.
- St Pierre S, Rommel J, Ciurea A, West D, Laumann A. High Resolution, High Magnification Capillary Videomicroscopy Imaging as a Useful Adjunct in the Assessment of Pharmacological Intervention (Tadalafil) for Secondary Raynaud's Phenomenon Due To Scleroderma and Mixed Connective Tissue Diseases. J Am Acad Dermatol 62:AB11, 2010. e-Pub 2010.
- Germani P, Wickless SC, Rosen S, Kuzel T, Ciurea A, Havey J, Guitart J. Applying the New TNM Classification System for Primary Cutaneous Lymphomas other than Mycosis Fungoides and Sezary Syndrome in Primary Cutaneous Marginal Zone Lymphoma. J Am Acad Dermatol 59(2):245-54, 2008. e-Pub 2008.
- Wickless S, Ciurea A, Gerami P, Guitart J. An Unusual Indolent Presentation of Intravascular B-cell Lymphoma in an Elderly Female. J Cut Pathol 35:91-9, 2008. e-Pub 2008.
- Krunic S, Ciurea A, Scheman A. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone. J Am Acad Dermatol 58(1):60-62, 2008. e-Pub 2008.
- Caruntu I, Ciurea A. Actinic Keratosis: A Histoenzymological Study. Morphol Embiol 15:132-135, 2000. e-Pub 2000.
- Caruntu I, Mihaila D, Ciurea A, Rascarachi G. Scoring Systems in the Histophthological Examination of the Hepatic Biopsy. Rev. Med. Chir. soc. Med. Nat 103:131-137, 1999. e-Pub 1999.
- Bostaca I, Ciurea A, de Pointes CSTAT. The Alcoholic Torsade de Pointes. Rev. Med. Chir. Soc. Med Nat III:86-88, 1996. e-Pub 1996.
- Bostaca I, Ciurea S, Jescu A. The Heart: spectator or Participant in Neoplasia? Carcinoid Heart Disease. Romania Update 6:246-251, 1996. e-Pub 1996.
- Bostaca S, Ciurea A, Jescu A, Florea M, Costachesu G. The Heart: Spectator or Participant in Neoplasia?. Med Chir. Soc. Med. Nat 6:53-61, 1995. e-Pub 1995.
Invited Articles
- Diaz L, Ciurea A. Cutaneous and systemic adverse reactions to antibiotics. Dermatol Ther 25(1):12-22, 2012. e-Pub 2012.
Review Articles
- Ciurea AM. Dermatologic toxicities associated with novel pan-RAS/RAF inhibitors. JCP. e-Pub 2025.
- Liu, YA, Ciurea, AM, Aung, PP. A diagnostic approach to basaloid neoplasms of the skin. Diagnostic Histopathology 30(1):60-76, 2024. e-Pub 2024.
Professional Educational Materials
- Ciurea AM. Q&A: Focus on Melanoma, 2013.
- Ciurea AM. Skin Cancer Screening: What Is It and Who Should Get It?, 2010.
- Halpern A, Ciurea AM, Berwick M, Geller A, Weinstock M, Hwu WJ, Federman D. The Jury Still Out on Wheather Skin Cancer Screening Saves Lives. HemOnc Today, 2009.
Abstracts
- Diaz L, Bicknell L, Ciurea A, Kapil J. Cylindromatous carcinoma arising in a scalp cylindroma. American Academy of Dermatology Meeting, 2013. e-Pub 2013.
- Vin H, Ojeda SS, Ching G, Leung ML, Chitsazzadeh V, Dwyer DW, Adelmann CH, Restrepo M, Richards KN, Stewart LR, Du L, Ferguson SB, Chakravarti D, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Kim KB, Ciurea AM, Duvic M, Prieto VG, Ullrich SE, Dalby KN, Flores ER, Tsai KY. BRAF Inhibitors Suppress Apoptosis Through Off-Target Inhibition of JNK Signaling. Elife 2:e00969, 2012. e-Pub 2012. PMID: 24192036.
- Morgan L, Diaz L, Hymes S, Ciurea A. Dupuytren's contractures secondary to BRAF inhibitor. American Academy of Dermatology Meeting, 2012. e-Pub 2012.
- Ciurea A, Prieto VG, Diaz L. Pigmented Paget's disease. American Academy of Dermatology Meeting, 2012. e-Pub 2012.
Book Chapters
- Ciurea AM. Vulvar Melanoma. In: Gynecologic Caring for the Female Cancer Patient. Cambridge, 2024.
- Ciurea, AM. Vulvar Melanoma, 383-393, 2024.
- Ciurea, AM, Margolin, K. Melanoma, 455-475, 2023.
- Ciurea A, Hymes S, Safdar A. Cutaneous Lesion that Mimic Infection in Organ Transplant Patients. In: Principles and Practice of Transplant Infectious Diseases. Springer, 397-416, 2019.
- Ciurea A. Epidemiology and clinical characteristics of melanoma. In: Genetics of Melanoma. Springer, 69-83, 2016.
- Ciurea A, Margolin K. Malignant melanoma. In: Cancer Consult: Expertise for Clinical Practice. Wiley-Blackwell Health Sciences, 635, 2014.
- Ciurea A, Hymes S. Skin Conditions Mistaken for Infection in the Transplant Population. In: Principles and Practice of Transplant Infectious Diseases. Ed. Safdar A. Springer, 2014.
- Hymes S, Chon S, Ciurea A. Cutaneous lesions that mimic infections. In: Principles and Practice of Cancer Infectious Diseases. Springer, 233-253, 2011.
Patient Reviews
CV information above last modified March 06, 2026